Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VCEL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
29 top institutions tracked
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 61 days ago
Red flags: 1
320 filers reported a long position in VCEL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $360M | 8.1M | +4.2% |
| STATE STREET CORP | $146.6M | 3.3M | +4.5% |
| CONGRESS ASSET MANAGEMENT CO | $129.7M | 2.9M | +93.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.4M | 2.3M | +1.1% |
| Conestoga Capital Advisors, LLC | $92.7M | 2.1M | -15.4% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $88.7M | 2M | +8.7% |
| BNP Paribas Asset Management Holding S.A. | $73M | 1.6M | -4.8% |
| GW&K Investment Management, LLC | $69M | 1.6M | -4.1% |
| Soleus Capital Management, L.P. | $64.9M | 1.5M | -42.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $59.7M | 1.3M | +6.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.